SSA
CRBU icon

Schonfeld Strategic Advisors’s Caribou Biosciences CRBU Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.5K Buy
+23,969
New +$41.1K ﹤0.01% 1987
2025
Q4 		– Sell
-558,576
Closed -$1.3M – 2130
2025
Q3 		$1.3M Sell
558,576
-1,714,290
-75% -$3.24M 0.01% 1256
2025
Q2 		$2.86M Sell
2,272,866
-78,716
-3% -$77.4K 0.02% 803
2025
Q1 		$2.15M Buy
2,351,582
+238,310
+11% +$310K 0.01% 933
2024
Q4 		$3.36M Buy
2,113,272
+467,738
+28% +$941K 0.02% 625
2024
Q3 		$3.23M Buy
1,645,534
+753,678
+85% +$1.54M 0.02% 696
2024
Q2 		$1.46M Sell
891,856
-951,058
-52% -$3.04M 0.01% 1044
2024
Q1 		$9.47M Buy
+1,842,914
New +$11.4M 0.06% 395
2022
Q4 		– Sell
-15,344
Closed -$162K – 2655
2022
Q3 		$162K Buy
15,344
+3,644
+31% +$34K ﹤0.01% 2413
2022
Q2 		$64K Sell
11,700
-3,100
-21% -$23.7K ﹤0.01% 2195
2022
Q1 		$136K Buy
+14,800
New +$156K ﹤0.01% 2137
2021
Q4 		– Sell
-10,500
Closed -$251K – 2202
2021
Q3 		$251K Buy
+10,500
New +$257K ﹤0.01% 1627

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Schonfeld Strategic Advisors's CRBU Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Caribou Biosciences (CRBU) in Q1 2026: 23,969 shares worth $45.5K. The stake represents ﹤0.01% of the portfolio and ranks #1987 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in CRBU as recently as Q3 2025.

Schonfeld Strategic Advisors first reported a position in CRBU in Q3 2021 and has held it in 12 quarters since. The position peaked at $9.47M in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Schonfeld Strategic Advisors held 23,969 shares of Caribou Biosciences worth $45.5K as of Q1 2026.
  • Caribou Biosciences was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1987 holding.
  • Schonfeld Strategic Advisors first reported a position in Caribou Biosciences in Q3 2021 and has held it in 12 quarters since.
  • Schonfeld Strategic Advisors's Caribou Biosciences position peaked at $9.47M in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.